Delivery Order SPE2DB22D1106-SPE2DB24FELR9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,688.03, is for the delivery of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and nicotine addiction. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support...
- This federal contract award, valued at $30,713.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 500-count bupropion HCL XL 300 mg tablets, a medication used to treat depression and other conditions. The contract has a completion date of February 7, 2024 and is a firm fixed-price delivery order. No set-aside designation was applied. AmerisourceBergen holds a significant Indefinite...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 150 mg Bupropion HCL XL tablets, a generic medication used for the treatment of depression. The award has a ceiling value of $1,160.61 and a completion date of December 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $12,620.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,077,741 tablets of Bupropion HCL XL 300 mg. The contract is a firm fixed-price delivery order with a performance period ending on April 30, 2025. This award is not designated as a set-aside and represents an open competition contract. Amerisourcebergen Drug Corp is a significant vendor for the DLA,...
- This federal contract award, valued at $2,537.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and other conditions. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $35,290.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bupropion HCL XL 150 mg tablets, a medication used to treat depression and to help people quit smoking. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $4,176.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,502,725 units of Bupropion HCL XL 300 mg tablets, a medication used to treat depression. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Bupropion HCL XL 150 mg tablets, a generic pharmaceutical product used to treat depression and other conditions. The contract has a ceiling value of $60,554.02 and is structured as a Firm Fixed Price delivery order, with a period of performance ending on April 30, 2024. This contract award...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,069.41 firm fixed-price delivery order is for the supply of 500 units of Bupropion HCL XL 150 mg tablets, a medication used for the treatment of depression and other mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The $1,647.38 firm-fixed-price delivery order is for the supply of 4,566,120 units of Bupropion HCL XL 150 mg tablets, a generic medication used to treat depression and smoking cessation. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FELR9Delivery Order
This federal contract award, valued at $58,566.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,286,845 units of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and certain other conditions. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $58.6k | 4/15/24 |